<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cardiac resynchronization therapy (CRT) is a commonly used procedure to help patients with drug refractory <z:hpo ids='HP_0001635'>heart failure</z:hpo> (HF) symptoms </plain></SENT>
<SENT sid="1" pm="."><plain>More patients with <z:hpo ids='HP_0002564'>congenital heart disease</z:hpo> (CHD) survive to adulthood with the improvements that have occurred as a result of surgical and medical care of these patients </plain></SENT>
<SENT sid="2" pm="."><plain>However, patients with CHD may develop ventricular dysfunction and HF and thus be considered for CRT </plain></SENT>
<SENT sid="3" pm="."><plain>In this review, we discuss the unique features of CRT in the adult CHD population </plain></SENT>
<SENT sid="4" pm="."><plain>We examine the existing data on utilization of CRT in patients with HF and CHD and specifically discuss the limitations in terms of benefit as well as data availability </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, we review the specific coronary sinus <z:mp ids='MP_0000002'>anatomy</z:mp> and technical considerations for placing a left ventricular lead in patients with CHD </plain></SENT>
</text></document>